PortfoliosLab logoPortfoliosLab logo
BAESY vs. CVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BAESY vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BAE Systems PLC (BAESY) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BAESY achieves a 11.25% return, which is significantly lower than CVS's 30.67% return. Over the past 10 years, BAESY has outperformed CVS with an annualized return of 18.72%, while CVS has yielded a comparatively lower 3.70% annualized return.


BAESY

1D
-4.00%
1M
-1.83%
YTD
11.25%
6M
13.51%
1Y
0.44%
3Y*
30.63%
5Y*
30.61%
10Y*
18.72%

CVS

1D
1.47%
1M
3.92%
YTD
30.67%
6M
30.57%
1Y
59.29%
3Y*
16.60%
5Y*
7.08%
10Y*
3.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BAESY vs. CVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BAESY
BAE Systems PLC
11.25%65.51%1.23%40.91%46.40%14.56%-3.43%34.69%-22.16%13.28%
CVS
CVS Health Corporation
30.67%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%

Correlation

The correlation between BAESY and CVS is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.03

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jul 13, 2007

0.23

The correlation between BAESY and CVS shifts across timeframes, from -0.06 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BAESY:

$77.52B

CVS:

$130.41B

EPS

BAESY:

£5.29

CVS:

$2.30

PE Ratio

BAESY:

14.41

CVS:

44.29

PS Ratio

BAESY:

1.06

CVS:

0.32

PB Ratio

BAESY:

4.92

CVS:

1.68

Total Revenue (TTM)

BAESY:

£54.56B

CVS:

$407.91B

Gross Profit (TTM)

BAESY:

£19.72B

CVS:

$56.59B

EBITDA (TTM)

BAESY:

£7.74B

CVS:

$9.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BAESY vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BAESY
BAESY Risk / Return Rank: 4141
Overall Rank
BAESY Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
BAESY Sortino Ratio Rank: 3838
Sortino Ratio Rank
BAESY Omega Ratio Rank: 3737
Omega Ratio Rank
BAESY Calmar Ratio Rank: 4343
Calmar Ratio Rank
BAESY Martin Ratio Rank: 4343
Martin Ratio Rank

CVS
CVS Risk / Return Rank: 8686
Overall Rank
CVS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 8282
Sortino Ratio Rank
CVS Omega Ratio Rank: 8787
Omega Ratio Rank
CVS Calmar Ratio Rank: 8888
Calmar Ratio Rank
CVS Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BAESY vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BAE Systems PLC (BAESY) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BAESYCVSDifference
Sharpe ratioReturn per unit of total volatility

-1.91

Sortino ratioReturn per unit of downside risk

-2.08

Omega ratioGain probability vs. loss probability

1.03

1.35

-0.33

Calmar ratioReturn relative to maximum drawdown

0.02

3.62

-3.61

Martin ratioReturn relative to average drawdown

0.04

9.33

-9.28

BAESY vs. CVS - Sharpe Ratio Comparison

The current BAESY Sharpe Ratio is 0.01, which is lower than the CVS Sharpe Ratio of 1.92. The chart below compares the historical Sharpe Ratios of BAESY and CVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BAESY vs. CVS - Drawdown Comparison

The maximum BAESY drawdown since its inception was -59.20%, smaller than the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for BAESY and CVS.


Loading charts...

Drawdown Indicators


BAESYCVSDifference

Max Drawdown

Largest peak-to-trough decline

-59.20%

-64.07%

+4.87%

Max Drawdown (1Y)

Largest decline over 1 year

-23.59%

-16.44%

-7.15%

Max Drawdown (3Y)

Largest decline over 3 years

-23.59%

-43.98%

+20.39%

Max Drawdown (5Y)

Largest decline over 5 years

-23.59%

-56.79%

+33.20%

Max Drawdown (10Y)

Largest decline over 10 years

-42.13%

-56.79%

+14.66%

Current Drawdown

Current decline from peak

-16.92%

0.00%

-16.92%

Average Drawdown

Average peak-to-trough decline

-19.32%

-19.54%

+0.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.17%

6.38%

+3.79%

Volatility

BAESY vs. CVS - Volatility Comparison

BAE Systems PLC (BAESY) has a higher volatility of 10.68% compared to CVS Health Corporation (CVS) at 7.50%. This indicates that BAESY's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BAESYCVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.68%

7.50%

+3.18%

Volatility (6M)

Calculated over the trailing 6-month period

25.10%

25.88%

-0.78%

Volatility (1Y)

Calculated over the trailing 1-year period

31.92%

31.05%

+0.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.12%

29.98%

-1.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.90%

29.30%

-1.40%

Dividends

BAESY vs. CVS - Dividend Comparison

BAESY's dividend yield for the trailing twelve months is around 1.90%, less than CVS's 2.61% yield.


PositionTTM20252024202320222021202020192018201720162015
BAESY
BAE Systems PLC
1.90%1.90%2.79%2.40%3.09%4.46%7.05%3.66%4.93%5.71%6.26%4.38%
CVS
CVS Health Corporation
2.61%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%

Financials

BAESY vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between BAE Systems PLC and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B202120222023202420252026
14.67B
100.43B
(BAESY) Total Revenue
(CVS) Total Revenue
Please note, different currencies. BAESY values in GBP, CVS values in USD

BAESY vs. CVS - Profitability Comparison

The chart below illustrates the profitability comparison between BAE Systems PLC and CVS Health Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

8.0%10.0%12.0%14.0%16.0%18.0%202120222023202420252026
9.2%
15.6%
Portfolio components
BAESY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BAE Systems PLC reported a gross profit of 1.34B and revenue of 14.67B. Therefore, the gross margin over that period was 9.2%.

CVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.

BAESY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BAE Systems PLC reported an operating income of 1.34B and revenue of 14.67B, resulting in an operating margin of 9.2%.

CVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.

BAESY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BAE Systems PLC reported a net income of 1.09B and revenue of 14.67B, resulting in a net margin of 7.4%.

CVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.


Frequently Asked Questions


BAESY and CVS have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BAESY has higher volatility (10.68%) compared to CVS (7.50%). In terms of maximum drawdown, BAESY dropped -59.20% vs CVS's -64.07%.

CVS currently has the higher Sharpe Ratio (1.92 vs 0.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BAESY and CVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer